Curatron PEMF for Osteoporosis
Osteoporosis is a degenerative bone disease resulting in decreased bone density and increased risk for fractures.
Bone mass refers to the amount of bone tissue contained in the skeleton. It can be expressed in terms of bone mineral content (the total grams of bone mineral within a given area of bone) or in terms of bone mineral density (the bone mineral content normalized for the projected area).
Tests that measure bone mineral are the basis for diagnosing osteoporosis and the predicting fracture risk.
Bone density usually peaks between the ages of 30 to 40. As we age, the creation of new bone starts to decrease. If the decrease is significant enough, the patient is at significant risk of fracture. These thresholds are reached at different ages and the extent of bone loss varies depending on the peak bone mass and generic and environmental factors, including activity level, diet, and medications. Lifestyle factors like malnutrition, smoking, excessive use of alcohol and an inactive lifestyle contribute to, and worsen, osteoporosis. It is not known whether this response derives from decreased osteoblastic activity, increased osteoclastic resorption, or both.
Osteoporosis patients often suffer from very painful micro-fractures in the vertebrae of the spine. Treatment with the Curatron PEMF system improves bone density, providing pain relief due to healing of the micro-fractures. Daily treatment with the Curatron device makes bones stronger and decreases fracture risk.
Curatron improves bone density! Study and testimonial:
I purchased the Curatron XP after being diagnosed with osteoporosis. The last thing I wanted to do was drug therapy. I gave myself one year using the Curatron mattress and high energy coil before returning to my specialist for a follow up bone scan.
The results were quite amazing a 10.4% increase in bone density in the area between L1 to L4. I have forwarded my old and new scans on to Ben at Curatronic and given him permission to share these results with anyone who would like to view them. My wife loves it for all sorts of ailments and my 15 year son is on it often for sporting injuries. It is the absolute best thing I have ever done for my overall health. GC –Australia.
Improvement of 8.8% in 18 months:
In January 2008, J.N., a trim, active 87 year old female, came in to the Viera Diagnostic Center and was diagnosed with a modern Lunar bone densitometer.
According to the classification of the World Health Organization, a T-score lower than -2.5 shows that a person suffers from osteoporosis.
The measured Bone Mass Density of J.N in her Spine was 0.785 g/sq.cm corresponding with a T-score of -3.3, affirming that she was suffering from severe osteoporosis.
Around June 2008 she purchased a Curatron XP device with a full body mattress and used it on a daily basis.
In December 2009, 18 months after starting treatment with the Curatron PEMF, she was diagnosed again at the same center. The measured values showed a huge improvement with a Bone Mass Density of 0.854 g/sq.cm corresponding with a T-score of -2.7, reflecting an improvement of 8.8% vs. her previous measured values! And all this within only 18 months!
Here is a scan of the report of Viera Diagnostic Center:
PEMF therapy for osteoporosis
During the past 15 years, low-energy time-varying electromagnetic fields have been used to treat non-union fractures. Electromagnetic fields modify biological behavior by inducing electrical changes around and within the cell. The key to rational use of electro-magnetic fields lies in the ability to define specific treatment parameters (amplitude, frequency, wave form, orientation and timing). Studies have shown an increase in bone density in osteoporosis-prone patients exposed to specific pulsed electromagnetic fields. Properly applied pulsed electromagnetic fields has clear clinical benefits for treatment of osteoporosis.
Our bones are responsive to the mechanical demands placed on them. During bed rest, immobilization and weightlessness, loading diminishes resulting in loss of bone mass. When loading is increased correctly, bone mass increases. Results of bio-mechanical and histological investigations prove that electromagnetic fields both prevent as well as restore lost bone mass.
A study at McGill University of Montreal found that electromagnetic fields damp bone resorption activity. The study showed that selected electro-magnetic fields increase bone formation. When energy of the imposed fields is concentrated in the lower frequency components, the resorption of bone is lowest and the formation of new bone the greatest. These results are consistent with other studies showing that cells respond to a broad spectrum of frequencies. They appear to be most sensitive to frequencies in the range of those produced in the range of 1000 Hz or less. Tissue dosimetry studies show that the frequency response of cortical bone over a range of 100 Hz to 20 kHz shows a steep roll off between 100 and 200 Hz.
A study at the Pacific Health Research Institute in Honolulu was designed to provide concrete data on the restoration of bone mass in post-menopausal females. Bone density rose with an average of 5.6%. A similar study at the University of Graz in Austria showed 6% increase in bone density after one year.
The proportionate increase in fracture risk is directly related to decreased bone density.
Electro-magnetic fields at specific frequencies have been shown to produce osteogenic effects in a turkey ulna model. In addition, low-amplitude signals decrease bone resorption in a canine fibular model.
A study “Prevention of osteoporosis by pulsed electromagnetic fields” by Clinton T. et.al. of the Department of orthopedics, State university of New York, Stony Brook, showed increased bone mass of 12.3 and 9.7 percent after PEMF treatment.
Another study led by Associate Prof. Dr. W. Passath and Prof. Dr. G. Leb of the Medical Clinic of the Karl Franzen University of Graz in Austria was designed to provide concrete data on the restoration of bone mass in post-menopausal females. A total of 36 female patients between the ages of 46 and 61, all with decreased bone mineral density as defined by a bone densitometer, were treated during a period of 8 to 12 weeks. One year after the study the average bone density had increased by 5.81 percent.
Measuring Bone Density
Bone density values in individuals are expressed in relation to a reference in Standard Deviation (SD) units.
in young and healthy women, If bone mineral density (BMD) is below 1 SD but not below 2.5 SD of the mean value of peak bone mass, than there is low bone mass (Osteopenia). If this value is lower than 2.5 SD below this value the patient has Osteoporosis.
Risk of fractures is inversely related to bone mass. As bone mass decreases, risk of fractures increases.
Even relatively small alterations in bone mass can lead to significant changes in the risk of fractures.
Common fractures in osteoporotic patients occur in the vertebrae, hip, and forearm.
Osteoporotic fractures are associated with significant morbidity and mortality. Due to crush fractures of vertebrae, a typical complaint of osteoporosis patients is acute or intermittent back pain following normal activity. The pain lasts a few days or weeks and then subsides. Such episodes recur and may result in chronic backache. As the disease progresses, loss of height, spinal deformity and fractures occur.
Hip fractures, in particular, frequently have grim prognosis. The mortality rate of osteoporotic hip fractures is between 15 % and 20 %, primarily due to pulmonary emboli, pneumonia, and other complications of surgery and prolonged hospitalization. The lifetime risk of hip fractures in white women is as great as the risk of breast, endometrial and ovarian cancer combined. One half of patients who survive a hip fracture are unable to walk unassisted and 25 % are confined to nursing homes.
Dual Energy X-ray Absorptiometry
In 1987 Dual Energy X-ray Absorptiometry (DXA or DEXA) was introduced. Today DXA equipment is widely available and this method is the choice for bone density measurements.
The basic technique of DXA is essentially the same as in DPA except for the radionuclide source, which is replaced with an X-ray source. DXA has several advantages over the older absorptiometry methods. Measurements take less time, exposing the patient to less radiation and most importantly the results of the measurements are more precise. With the development of p-DXA technique it became possible to measure the density of the forearm in a reasonably accurate way, both mid-distal and ultra-distal during the same scan.
Single Energy X-ray Absorptiometry
Instead of using a radio nuclide photon source as in SPA, an X-ray source is used in Single Energy X-ray Absorptiometry (SXA), though this method cannot be used at the spine and hip.
Single- and Dual Photon Absorptiometry
Single photon absorptiometry (SPA) was initially developed in 1963. This technique involves passing a focused beam of radionuclide radiation across the arm. Because denser tissue (bone) blocks radiation better than soft tissue does, bone density can be deducted from these differences.
One disadvantages of this technique is the requirement for uniform soft tissue around the bone to be measured. Furthermore, it is impossible to use this technique when measuring bone density of the hip and spine, sites that are more vulnerable to fractures.
However, SPA has provided important population-based information in epidemiological studies, specifically on the effects of aging of the skeleton.
A more sophisticated version of the same technology used in SPA is dual photon absorptiometry (DPA).
This technique was developed in the early 1970s and the first systems became commercially available in 1980.
DPA uses a radioactive isotope, which emits radiation at two different energy levels, instead of the single energy level used for SPA measurements.
While the body is scanned, the two energy levels are detected and used for mathematical calculations in order to obtain different values for the different amounts of transmissions of the energy through the body. By using this method more accurate bone density values are obtained.
Quantitative Computed Tomography
Quantitative Computed Tomography (QCT) represents a modification of conventional CT scanners.
The image produced by CT is generated by computer analysis of numerous X-ray transmission values obtained in different directions. The X-ray source and detector rotate around a patient in a fixed plane. From these CT scans bone density is calculated by reference to the density of calibrated phantoms.
Radiation exposure is substantially higher than with other bone density measuring techniques. This form of measurement is useful in elderly patients who may have age-related osteoarthritis and aortic calcification interfering with absorptiometric measurements.
An outdated technique where bone density is determined from X-ray films by reference to a metal calibration wedge placed alongside the hand during an X-ray procedure. Radiographic densitometry is then used to correlate to bone density measurements, but this .
During the last few years various new machines have been introduced for the assessment of skeletal status.
By means of Quantitative Ultrasound (QUS), measurements are performed at patella, heel bone, tibia, and ulna.
Mainly the Broadband Ultrasound Attenuation (BUA) and Velocity or Speed of Sound (SOS) are calculated. The systems yield quantitative results averaged over the measurement area, while the Quantitative Ultrasound Index (QUI) and some calcaneal systems also generate an image.
Ultrasound systems have the advantage of obtaining information without the need for ionizing radiation. However, the amount of radiation emitted by modern p-DXA systems is extremely low in comparison. The main reason for purchasing an ultrasound system is the lower price and portability of these devices compared with p-DXA machines.
Long term studies of QUS changes over time are still limited. Expressing measurement results on a percentage level is misleading because of the different units and calibrations employed. Studies indicate that standardized precision errors of QUS approaches are at least two times higher compared to corresponding DXA results.
Since this technique does not derive absolute data on bone mineral density, QUS can be used only for fracture risk prediction.
Chemical measurements of blood and urine by biochemical screening assays (bone markers) are used to evaluate bone resorption and formation.
Although biochemical screening assays have improved over the last few years, they still have an accuracy error of up to 30%.
They are only useful for studying bone turnover in large groups of patients where individual errors are statistically compensated.
Chemical analyses such as urinary hydroxyproline and pyridinoline crosslinks or serum alkaline phosphatase cannot be used to diagnose osteoporosis. Usually they cannot be used to evaluate an imbalance between formation and destruction of bone. They are however useful in determining bone turnover, and consequently in identifying patients who are likely to be fast bone losers.